CareerExamPro

ONCC ROCN Radiation Oncology, AACN CMC/CSC & NCC C-OBE (2026) practice questions

20 questions from the ROCN, CMC/CSC, C-OBE, BCPMP & NRCME practice test.

Start practising

ONCC ROCN Radiation Oncology, AACN CMC/CSC & NCC C-OBE (2026) practice drill

10 realistic exam questions, graded as you go, with the exact rule or statute citation for every answer. Start free, no sign-up.

Sample questions

A 9-year-old child with a posterior fossa medulloblastoma is scheduled for craniospinal irradiation. The radiation oncology team selects proton beam therapy over photon-based intensity-modulated radiation therapy (IMRT). Which dosimetric property of proton beams primarily explains this clinical advantage?

  1. Protons exhibit exponential depth-dose attenuation beyond the target, creating a wider low-dose exit bath that sterilizes microscopic subclinical disease.
  2. Protons possess higher linear energy transfer than alpha particles, allowing single-fraction tumor ablation without requiring daily image-guided immobilization.
  3. Protons deposit peak energy at a finite depth (the Bragg peak) with virtually no distal exit dose, sparing anterior organs such as the heart, lungs, and bowel.
  4. Protons bypass superficial skin entirely with zero entrance dose, completely eliminating acute radiation dermatitis regardless of beam energy or field size.
Show the answer

C. Protons deposit peak energy at a finite depth (the Bragg peak) with virtually no distal exit dose, sparing anterior organs such as the heart, lungs, and bowel.

Charged proton particles deliver a relatively low entrance dose, release maximum ionizing energy at a predictable, energy-dependent depth known as the Bragg peak (spread across the tumor via a spread-out Bragg peak), and drop abruptly to virtually zero exit dose distally. In pediatric craniospinal irradiation, eliminating exit dose dramatically reduces integral radiation exposure to anterior developing tissues (heart, lungs, thyroid, GI tract, and gonads) compared with megavoltage photon IMRT, which still delivers an exit dose bath.

Reference: ONCC ROCN 2026 Blueprint (Radiation Physics & Modalities) / ASTRO Proton Beam Therapy Model Policy

A 64-year-old patient with endometrial cancer completes an outpatient high-dose-rate (HDR) vaginal cuff brachytherapy fraction delivered via an iridium-192 remote afterloader. After the applicator is removed and a Geiger-Mueller survey confirms background radiation levels, the patient asks whether she must stay separated from her infant grandchild tonight. How should the nurse respond?

  1. Maintain a minimum distance of six feet from infants and pregnant individuals for at least 72 hours while residual gamma radiation decays from the vaginal mucosa.
  2. Flush the toilet twice after every void and wash personal linens separately for seven days to prevent body-fluid radiation contamination at home.
  3. Sleep in a separate bedroom for two weeks and wear a lead-impregnated undergarment when holding children under age five during the first month.
  4. No radiation isolation precautions are needed after discharge because the HDR source is fully retracted and no radioactivity remains in the body.
Show the answer

D. No radiation isolation precautions are needed after discharge because the HDR source is fully retracted and no radioactivity remains in the body.

HDR brachytherapy uses a high-activity sealed source (typically Ir-192) delivered briefly through an applicator inside a shielded vault via a remote afterloader. Once the source retracts back into the safe and the mandatory post-treatment radiation survey confirms background readings, the patient retains zero radioactivity and poses no radiation hazard to family members, infants, or pregnant individuals. Isolation or distance precautions apply to permanent LDR implants (e.g., I-125/Pd-103 seeds) or unsealed systemic radiopharmaceuticals (e.g., I-131), not HDR treatments.

Reference: ONCC ROCN 2026 Blueprint (Brachytherapy Safety) / NRC 10 CFR 35.604 & ONS Clinical Practice Resources

During week 5 of whole-breast external beam radiation therapy (EBRT), a patient develops patchy moist desquamation with serous exudate and tenderness in the inframammary fold (CTCAE Grade 2). Which nursing intervention aligns with evidence-based radiation dermatitis management?

  1. Apply a thick layer of zinc oxide barrier paste over the inframammary fold 30 minutes before each daily fraction to protect exposed dermis from scatter.
  2. Cleanse gently with lukewarm water, apply a non-adherent hydrogel or silicone foam dressing, and avoid heavy ointments right before beam delivery.
  3. Scrub the weeping area twice daily with chlorhexidine solution, leave it open to dry heat from a warm hair dryer, and secure gauze with paper tape.
  4. Apply over-the-counter 1% silver sulfadiazine cream immediately prior to each radiation session and instruct the patient to stop washing the treated breast.
Show the answer

B. Cleanse gently with lukewarm water, apply a non-adherent hydrogel or silicone foam dressing, and avoid heavy ointments right before beam delivery.

Moist desquamation requires moist wound healing with gentle cleansing (lukewarm water and mild pH-neutral cleanser if needed), patting dry, and atraumatic non-adherent dressings such as hydrogel sheets or soft silicone foam without adhesive tape in the field. Thick metallic or petroleum-based ointments (such as zinc oxide or silver sulfadiazine) applied right before treatment can act as a tissue-equivalent bolus, increasing surface radiation dose and worsening skin injury; harsh antiseptics, scrubbing, and heat further damage regenerating keratinocytes.

Reference: ONS Guidelines for Cancer Treatment-Related Skin Toxicities / MASCC Radiodermatitis Clinical Practice Guidelines

Other topics